Alnylam Pharmaceuticals | ALNY

Aktienkurs
231.83
Täglich Wechseln
-2.20 -0.94%
Monatlich
-5.57%
Jährlich
-51.87%
Q4 Prognose
227.63

EPS Referenz Zeit Aktuell Konsens Zuletzt
2026-10-29 FY2026Q3 AM 1.97 2.90
2026-07-30 FY2026Q2 AM 1.84 1.61 0.32
2026-04-30 FY2026Q1 AM 1.99 0.99 -0.01
2026-02-12 FY2025Q4 AM 1.25 1.27 0.06
2025-10-30 FY2025Q3 AM 2.90 0.27 -0.50



Preis Chg Tag Jahr Datum
Takeda 6,223.00 40.00 0.65% 48.48% 2026-10-16
Acadia Pharmaceuticals 19.12 -0.59 -2.99% -8.47% 2026-10-16
Agios Pharmaceuticals 31.35 -0.97 -3.00% -25.94% 2026-10-16
Alnylam Pharmaceuticals 231.83 -2.20 -0.94% -51.87% 2026-10-16
Amgen 432.49 -1.54 -0.35% 44.74% 2026-10-16
Arrowhead Research 55.90 -2.60 -4.44% 51.86% 2026-10-16
Tectonic Therapeutic 20.65 -0.65 -3.05% 19.64% 2026-10-16
BioCryst Pharmaceuticals 7.79 -0.23 -2.87% 17.50% 2026-10-16
BioMarin Pharmaceutical 54.68 -1.37 -2.44% 2.61% 2026-10-16
Incyte 113.13 -0.14 -0.12% 29.19% 2026-10-16

Preis Tag Jahr Datum
USND 26140 -572.99 -2.15% 15.26% 2026-10-16